GI/Noncolorectal Cancer

Clinical News
Chronic Liver Conditions Increase Risk of Death in COVID-19 Patients
eMediNexus, 17 November 2020
#Business And Medicine #Emergency Medicine #Gastroenterology #Hematology #Hospital Medicine

Patients with chronic liver disease had an increased risk for poor COVID-19 outcomes, and liver-specific risk factors include al ...MORE

543 Views
0 Comments

Journal Updates
Laparoscopic Surgery Appears Safe in Early Gastric Cancer
eMediNexus, 26 August 2020
#Gastroenterology #General Surgery #Hematology #Oncology #Pathology and Lab Medicine

A randomized trial, published in JAMA Oncology, has revealed that laparoscopic surgery, performed by an experienced sur ...MORE

595 Views
0 Comments

Journal Updates
Recent-Onset Diabetes, Weight Loss Linked with Cancer in 30-Year Study
eMediNexus, 14 August 2020
#Diabetes and Endocrinology #Hematology #Oncology #Pathology and Lab Medicine #Pharmacist

Individuals with recent-onset diabetes associated with weight loss appeared to have an increased risk for pancreatic cancer and ...MORE

609 Views
0 Comments

Clinical News
FDA Approves Nivolumab for Second-Line Esophageal Cancer
eMediNexus, 14 June 2020
#Dental Oral and Maxillofacial Surgery #Gastroenterology #Internal Medicine #Oncology #Pathology and Lab Medicine

The FDA has granted approval to single-agent nivolumab as a second-line treatment for advanced esophageal squamous cell carcinom ...MORE

643 Views
0 Comments

Clinical News
FDA Approves First-Line Immunotherapy in Liver Cancer
eMediNexus, 02 June 2020
#Gastroenterology #Hematology #Oncology #Pathology and Lab Medicine #Pharmacist

The FDA has granted approval to the PD-L1 immune checkpoint inhibitor atezolizumab for the first-line treatment of unresectable ...MORE

561 Views
0 Comments

Clinical News
FDA Approves First Drug for Fourth-Line Treatment of Advanced Gastrointestinal Stromal Tumors
eMediNexus, 16 May 2020
#Gastroenterology #Hematology #Internal Medicine #Oncology #Pathology and Lab Medicine

The U.S. Food and Drug Administration has granted approval to ripretinib as the first new drug approved as a fourth-line treatme ...MORE

632 Views
0 Comments
Prev123Next